Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zelenko Labs is a private consumer health and nutraceutical company commercializing dietary supplements associated with Dr. Vladimir Zelenko's "Zelenko Protocol" brand. The business markets over-the-counter wellness products such as Z-Stack, Z-Flu, Z-DTox, Z-Shield, and pediatric immune-support formulations through direct-to-consumer e-commerce channels. Based on available public information, it is not a traditional biotech or pharmaceutical developer and does not appear to run a clinical-stage therapeutic pipeline. Its products are sold as supplements and wellness products rather than FDA-approved drugs, with website disclaimers stating they are not intended to diagnose, treat, cure, or prevent disease. The requested name "Zelenko Protocol" appears to refer primarily to a branded treatment concept and associated product ecosystem, while the underlying company is Zelenko Labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zelenko Protocol.